PALMISANO ROBERT J → AEON Biopharma, Inc. AEON

Stake: 5.70% Shares: 2,265,000 CUSIP: 00791X100 Class: Class A Common Stock

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 11/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: -65.9%

Passive Schedule 13G filer baseline
Short interest building (+49.7% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

1 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.52

3,250,700 shares short · +49.7% vs prior

Post-Filing Returns · since 2024-07-25 on AEON

+1 day

-10.2%

+5 days

-33.4%

+30 days

-68.1%

+60 days

-76.5%

+90 days

-65.9%

+180 days

-95.6%

Anchor price 210.96 on closest trading day on/after 2024-07-25. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-08-19	LYNCH TIMOTHY P	10%+ owner	Buy	1,150,000	$0.21	$243K

Other 13D/G Filings on AEON Biopharma, Inc.

Filed	Form	Filer	Stake	Shares
2026-08-21	SCHEDULE 13G	LYNCH TIMOTHY P	—	—	view →
2026-07-21	SCHEDULE 13G	Stonepine Capital Management, LLC	—	—	view →
2026-01-29	SCHEDULE	Daewoong Co., Ltd	90.00%	91,357	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →